Health & Medicine, Life Science
Stella Therapeutics, a privately held drug discovery company, is developing first-in-class small molecules that hold the promise of curing Glioblastoma Multiforme (GBM), the most common and deadliest malignant brain tumor, while maintaining patient quality of life.
Dr. Nephi Stella
Professor of Pharmacology, Psychiatry and Behavioral Sciences at the University of Washington
is currently a Director of Capstone Therapeutics (CAPS)
has more than 25 years’ experience in founding, managing and growing technology and biotech startup companies. Currently, President & CEO of Point of Data